ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
10
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,478
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Episodic retreatment versus scheduled maintenance therapy of Crohn’s disease with infliximab: Not so far apart
Author(s):
R.Balfour Sartor
Publication date
Created:
February 2004
Publication date
(Print):
February 2004
Journal:
Gastroenterology
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Gastroenterology
Author and article information
Journal
Title:
Gastroenterology
Abbreviated Title:
Gastroenterology
Publisher:
Elsevier BV
ISSN (Print):
00165085
Publication date Created:
February 2004
Publication date (Print):
February 2004
Volume
: 126
Issue
: 2
Pages
: 598-601
Article
DOI:
10.1053/j.gastro.2003.12.019
SO-VID:
52dd108d-87a2-4e87-80c1-5b194b2744fb
Copyright ©
© 2004
License:
https://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
4,478
A Case of Breast Cancer Following Infliximab Treatment for Treatment-Refractory Crohn’s Disease
Authors:
Vedat Goral
,
Belkis Unsal
,
Oya Nermin Sivrikoz
Seven weeks of high-dose vitamin D treatment reduces the need for infliximab dose-escalation and decreases inflammatory markers in Crohn’s disease during one-year follow-up
Authors:
M. Bendix
,
A Dige
,
SP Jørgensen
…
Decrease in mucosal IL17A, IFNγ and IL10 expressions in active Crohn’s disease patients treated with high-dose vitamin alone or combined with infliximab
Authors:
M. Bendix
,
A Dige
,
SP Jørgensen
…
See all similar
Cited by
10
Enteric Flora in Health and Disease
Authors:
Francisco Guarner
Gut Microbiota and Inflammatory Bowel Disease
Authors:
Heinz Hammer
,
H.F. Hammer
The c.1-260C>T Promoter Variant of CD14 but Not the c.896A>G (p.D299G) Variant of Toll-Like Receptor 4 (TLR4) Genes Is Associated with Inflammatory Bowel Disease
Authors:
Daniel Baumgart
,
Carsten Büning
,
Lars Geerdts
…
See all cited by